Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)

Published:2014-07-09 Issue:22 Volume:120 Page:3575-3583
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Barton Debra L.¹,Thanarajasingam Gita¹,Sloan Jeff A.²,Diekmann Brent²,Fuloria Jyotsna³,Kottschade Lisa A.¹,Lyss Alan P.⁴,Jaslowski Anthony J.⁵,Mazurczak Miroslaw A.⁶,Blair Scott C.⁷,Terstriep Shelby⁸,Loprinzi Charles L.¹

Affiliation:

1. Mayo Clinic Rochester; Rochester Minnesota

2. Alliance Statistics and Data Center; Mayo Clinic; Rochester Minnesota

3. Ochsner CCOP; New Orleans Louisiana

4. Heartland Cancer Research CCOP; St. Louis Missouri

5. St. Vincent Regional Cancer Center CCOP; Green Bay Wisconsin

6. Sioux Community Cancer Consortium; Sioux Falls South Dakota

7. Columbus CCOP; Columbus Ohio

8. Meritcare Hospital CCOP; Fargo North Dakota

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28892/fullpdf

Reference32 articles.

1. Frequency and clinical implications of delayed nausea and delayed emesis;Morrow;Am J Clin Oncol,1996

2. The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers;Ihbe-Heffinger;Ann Oncol,2004

3. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment;Bloechl-Daum;J Clin Oncol,2006

4. Chemotherapy-induced nausea and vomiting;Hesketh;N Engl J Med,2008

5. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy;Tina Shih;Cancer,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of pregabalin for the prevention of chemotherapy induced nausea and vomiting;O Mundo da Saúde;2024-01-01

2. Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)—a systematic review and individual patient data meta-analysis;Supportive Care in Cancer;2023-08

3. Zentrales Nervensystem;Arzneimitteltherapie in der Palliativmedizin;2022

4. Real‐world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed‐dose combination to prevent chemotherapy‐induced nausea and vomiting among Malaysian patients receiving moderately or highly emetogenic chemotherapy;Asia-Pacific Journal of Clinical Oncology;2021-11-23

5. Quality of Life as a Mediator between Cancer Stage and Long-Term Mortality in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Radiotherapy;Cancers;2021-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3